• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

76.7500 SEK 0.6500 0.85%

As of 11:29:59 ET on 09/17/2014.

Company Profile for Swedish Orphan Biovitrum AB (SOBI)

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Contact Information

Swedish Orphan Biovitrum AB

Berzelius vaeg 8
Stockholm, SE-12276
Sweden
Phone: 46-8-697-20-00
Fax: 46-8-697-23-30

Key Executives for Swedish Orphan Biovitrum AB (SOBI)

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
Dennis PedersenSenior VP/Head:MFG OpsFredrik BergVP/Gen Cnsl/Head:Legal & IP
Stefan FraenkelVP/Head:Corporate DevelopmentStephen JamesVP/Head:Drug Design & Dev
Cecilia ForbergVP/Head:Project & PortfolioAnders EdvellVP/Head:Sobi Partner Products
Jorgen WinrothVP/Head:Investor RelationsWills Hughes-WilsonVP:External Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil